Severe exacerbations in moderate-to-severe asthmatics are associated with increased pro-inflammatory and type 1 mediators in sputum and serum
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2466
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Severe exacerbations in moderate-to-severe asthmatics are associated with increased pro-inflammatory and type 1 mediators in sputum and serum ; volume:19 ; number:1 ; day:8 ; month:8 ; year:2019 ; pages:1-10 ; date:12.2019
BMC pulmonary medicine ; 19, Heft 1 (8.8.2019), 1-10, 12.2019
- Urheber
-
Ghebre, Michael A.
Pang, Pee Hwee
Desai, Dhananjay
Hargadon, Beverley
Newby, Chris
Woods, Joanne
Rapley, Laura
Cohen, Suzanne E.
Herath, Athula
Gaillard, Erol A.
May, Richard D.
Brightling, Chris E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12890-019-0906-7
- URN
-
urn:nbn:de:101:1-2019122907100174150303
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ghebre, Michael A.
- Pang, Pee Hwee
- Desai, Dhananjay
- Hargadon, Beverley
- Newby, Chris
- Woods, Joanne
- Rapley, Laura
- Cohen, Suzanne E.
- Herath, Athula
- Gaillard, Erol A.
- May, Richard D.
- Brightling, Chris E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review
Cost-Effectiveness of Acthar Gel Versus Standard of Care for the Treatment of Exacerbations in Moderate-to-Severe Systemic Lupus Erythematosus
Increased Small Intestinal Permeability during Severe Acute Exacerbations of COPD
Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
Omalizumab in patients with severe asthma and persistent sputum eosinophilia
Management of severe acute exacerbations of COPD: an updated narrative review
Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
Celiac Disease in Children with Moderate-to-Severe Iron-deficiency Anemia
Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthma
Teprotumumab: The Dawn of Therapies in Moderate-to-Severe Thyroid-Associated Ophthalmopathy
MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review
Health Economic Assessment of Optimal Biological Treatment for Moderate-to-Severe Psoriasis
Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review
Cost-Effectiveness of Acthar Gel Versus Standard of Care for the Treatment of Exacerbations in Moderate-to-Severe Systemic Lupus Erythematosus
Increased Small Intestinal Permeability during Severe Acute Exacerbations of COPD
Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
Omalizumab in patients with severe asthma and persistent sputum eosinophilia
Management of severe acute exacerbations of COPD: an updated narrative review
Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
Celiac Disease in Children with Moderate-to-Severe Iron-deficiency Anemia
Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthma
Teprotumumab: The Dawn of Therapies in Moderate-to-Severe Thyroid-Associated Ophthalmopathy
MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review
Health Economic Assessment of Optimal Biological Treatment for Moderate-to-Severe Psoriasis
Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review
Cost-Effectiveness of Acthar Gel Versus Standard of Care for the Treatment of Exacerbations in Moderate-to-Severe Systemic Lupus Erythematosus
Increased Small Intestinal Permeability during Severe Acute Exacerbations of COPD
Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
Omalizumab in patients with severe asthma and persistent sputum eosinophilia
Management of severe acute exacerbations of COPD: an updated narrative review
Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
Celiac Disease in Children with Moderate-to-Severe Iron-deficiency Anemia
Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthma
Teprotumumab: The Dawn of Therapies in Moderate-to-Severe Thyroid-Associated Ophthalmopathy
MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review